Marvin L. Woodall

Chairman of the Board

Mr. Woodall's distinguished career at Johnson & Johnson spanned nearly 37 years. From 1988 until 1996, he held the office of President of Johnson & Johnson Interventional Systems, Inc., leading the team responsible for pioneering the company's cardiovascular franchise into a $1 billion division. His tenure there included the development and launch of the PALMAZ-SCHATZ® Coronary Stent, which was designated as "the most important new medical device in the past 15 years" in a survey of medical device company CEOs in 1996. Mr. Woodall retired from Johnson & Johnson in 2001 and immediately became the Chairman of the Board of the Lehigh Valley Hospital and Health Network, which has received multiple awards as one of the leading hospital systems in America. He has served on the Board of Directors for Doylestown Hospital. Mr. Woodall is currently CEO of the Cardiovascular Research Foundation in New York City, and serves on the Board of Directors of the International Society of Endovascular Specialists in Phoenix and CardioMEMs, Inc., a cardiovascular device company in Atlanta.

Education:

Patricia K. Scheller

President and Chief Executive Officer

Ms. Scheller's commitment to the healthcare industry spans more than 20 years. Prior to joining Prescient Medical, she was the CEO of SomaLogic, a molecular diagnostic company dedicated to developing protein signature arrays. Ms. Scheller also managed several business units at Ortho-Clinical Diagnostics and was director of cardiology systems at Cordis, a Johnson & Johnson company renowned for pioneering vascular disease treatments. There, she was responsible for launching the first PALMAZ-SCHATZ® balloon-expandable Stent in the United States. Ms. Scheller also served in key executive positions at Dade Behring, a clinical diagnostics firm.

Education:

Undergraduate
B.S.E., Biomedical Engineering, Duke University
Executive Business Programs
Harvard Business School
MIT Sloan School of Management
Columbia University
Kellogg School of Management at Northwestern University

James G. Benedict, Ph.D.

Director

Dr. Benedict is a Principal at Kidd & Company, a principal investment firm. James joined Kidd & Company from Spencer Trask, a venture capital firm where he served as Senior Managing Director & Chief Talent Officer. Prior to joining Spencer Trask James was Managing Director and Co-Head of the E-Commerce and Technology Practice for the Diversified Search Companies. He joined the Diversified Search Companies via Diversified’s acquisition of RLM Associates, where he was Co-Founder and Partner. James has also served as a consultant to the World Bank and the Japanese Ministry of Finance. James earned a Ph.D. in International Economics from Columbia University, a Certificate on Monetary and Fiscal Policy from the Japanese Ministry of Finance, and a Bachelor of Arts (Honors Program Graduate with Distinction) from Baylor University.

Education:

Undergraduate
B.A., Honors Program, Baylor University
Graduate
Certificate on Monetary and Fiscal Policy, Japanese Ministry of Finance
Ph.D., International Economics, Columbia University

David P. Hochman

Director

Mr. Hochman is Managing Partner of Orchestra Partners LLC, a strategy consulting firm focused on venture-stage healthcare companies. Prior to Orchestra, he was CEO of Spencer Trask Edison Partners LLC, an investment affiliate of Spencer Trask & Co., focused on medical device and biotechnology. For 6 years, he was a Managing Director of Spencer Trask Ventures, Inc. and was responsible for directing the firm’s investment banking and strategic advisory services. Mr. Hochman is a board member of The Immune Response Corporation and Modigene, Inc. He is also a member of the Board of AIDS Action Foundation and of Citizens for NYC, non-profit organizations.

Education:

Undergraduate
B.G.S., University of Michigan

Joel Kanter

Director

Mr. Kanter has served as President of Windy City, Inc., a privately held investment firm, since 1986. From 1995 to 1999, Mr. Kanter served as the Chief Executive Officer and President of Walnut Financial Services, Inc., a publicly traded company. Walnut Financial was acquired by THCG, Inc. in 1999 in a transaction that ultimately provided approximately $300 million in market value to the shareholders. Mr. Kanter serves on the Board of Directors of several public companies including Encore Medical Corporation, I-Flow Corporation, Logic Devices, Inc., Magna- Lab, Inc., Nesco Industries, and Prospect Medical Holdings, Inc.

Education:

Undergraduate
B.A., Political Science, Tulane University
B.S., Psychology, Tulane University

Kurt Krauss

Director

Mr. Krauss has over 20 years of strategic repositioning and operational restructuring experience across a range of industries and companies. Presently, Mr. Krauss is the Managing Member of Sachem Investments LLC, an investment company he founded in 2001. From 1997 to 2000, he was the Chief Financial Officer of Burson-Marsteller, a public relations and marketing firm. He currently serves on the Board of Directors of Loudeye Corporation, where he is member of the Audit, Compensation, Nominating and Governance Committees.

Education:

Undergraduate
B.A.,  Mathematics, Heidelberg College
Graduate
M.S., Industrial Administration, Carnegie-Mellon University

Louis L. Liebhaber

Director

Mr. Liebhaber is a principal and founder of Fundamental Success. From 1994 to 2006, he was Chief Operating Officer of Lehigh Valley Hospital, where he managed the hospital operations for three hospitals with a total of 817 beds. Previously, Mr. Liebhaber had served for over ten years as Vice President for Operations at Beth Israel Medical Center in New York. Mr. Liebhaber is a member of the Boards of Directors of the United Way of Greater Lehigh Valley and Team Capital Bank.

Education:

Undergraduate
B.A., Brandeis University
Graduate
M.B.A., Health Care Management, Boston University Graduate School of Management 

Richard O. Martin, Ph.D.

Director

Dr. Martin retired as President of Medtronic Physio-Control Corp. (Physio) in 2001. Dr. Martin became President of Physio in 1991, when it was still part of Eli Lilly, where he instituted company-wide quality improvement programs, rebuilt the management team and assisted in the company’s initial public offering. In September 1998, the company merged with Medtronic, Inc. Prior to that, he was Vice President, Cardiovascular Business Development, with Sulzermedica, Inc. Dr. Martin has served on the Board of the Northwest affiliate of the American Heart Association and was its Chairman from 1997-1999. He has also served on the Board of the Medical Device Manufacturers Association on the Washington Council of AEA (formerly American Electronics Association), as well as on the Boards of Directors of Cardiodynamics International, Encore Orthopedics, Inovise Medical, MDdatacor, Cardiac Dimensions and Endo Gastric Solutions.

Education:

Undergraduate
B.S., Electrical Engineering, Christian Brothers College
Graduate
M.S., Electrical Engineering, Notre Dame
Ph.D., Electrical Engineering, Duke University